» Articles » PMID: 2786135

The Incidence of Non-melanocytic Skin Cancers in an Australian Population: Results of a Five-year Prospective Study

Overview
Journal Med J Aust
Specialty General Medicine
Date 1989 May 1
PMID 2786135
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Two thousand, six hundred and sixty-nine persons who were aged 40 years and older attended for examination of the light-exposed areas of the head and neck, forearms and dorsa of the hands during a skin-cancer survey of the population of Maryborough, which was conducted annually for five years from 1982-1986 inclusive. Sixty (2.25%) persons--12 persons each with a squamous-cell carcinoma and 48 persons with a total of 51 basal-cell carcinomas--had at least one non-melanocytic skin cancer at the first examination. One thousand, nine hundred and eighty-one (74% of the study population) persons were seen on more than one occasion, which allowed for 6288 person-years of follow-up for the determination of the incidence of new cancers. The findings showed a calculated minimal age-standardized incidence rate of 873 non-melanocytic skin cancers/100,000 population each year. The minimal incidence rate for basal-cell carcinomas was 672 cases/100,000 population each year and for squamous-cell carcinomas was 201 cases/100,000 population each year. The rate ratio of the incidence of basal-cell carcinomas to that of squamous-cell carcinomas was 3.34 to one. Age, sex, skin reaction to sunlight and occupation all were significant factors in the determination of the risk of developing non-melanocytic skin cancers. The enormous costs that are involved in the treatment of non-melanocytic skin cancers and related lesions suggest that more time, effort and money need to be spent to reduce what has become a major public-health problem in Australia.

Citing Articles

Occupational solar exposure and basal cell carcinoma. A review of the epidemiologic literature with meta-analysis focusing on particular methodological aspects.

Wendt A, Mohner M Eur J Epidemiol. 2024; 39(1):13-25.

PMID: 38170370 PMC: 10810945. DOI: 10.1007/s10654-023-01061-w.


The incidence and clinical analysis of non-melanoma skin cancer.

Ciazynska M, Kaminska-Winciorek G, Lange D, Lewandowski B, Reich A, Slawinska M Sci Rep. 2021; 11(1):4337.

PMID: 33619293 PMC: 7900109. DOI: 10.1038/s41598-021-83502-8.


Burden of non-melanoma skin cancer attributable to occupational sun exposure in Canada.

Peters C, Kim J, Song C, Heer E, Arrandale V, Pahwa M Int Arch Occup Environ Health. 2019; 92(8):1151-1157.

PMID: 31270593 DOI: 10.1007/s00420-019-01454-z.


Validating the use of Medicare Australia billing data to examine trends in skin cancer.

Perera E, Gnaneswaran N, Perera M, Sinclair R F1000Res. 2016; 4:1341.

PMID: 26937270 PMC: 4752029. DOI: 10.12688/f1000research.7161.1.


How to treat actinic keratosis? An update.

Costa C, Scalvenzi M, Ayala F, Fabbrocini G, Monfrecola G J Dermatol Case Rep. 2015; 9(2):29-35.

PMID: 26236409 PMC: 4517799. DOI: 10.3315/jdcr.2015.1199.